The BET Inhibitor OTX015 (MK-8628) Shows in Vivo Antitumor Activity in Combination with Additional Targeted Agents in Diffuse Large B-Cell Lymphoma (DLBCL)

被引：0
|
作者：
Gaudio, Eugenio [1 ]
Cascione, Luciano [1 ]
Ponzoni, Maurilio [2 ]
Tarantelli, Chiara [1 ]
Bernasconi, Elena [1 ]
Riveiro, Maria Eugenia [3 ]
Cvitkovic, Esteban [3 ]
Zucca, Emanuele [4 ]
Bertoni, Francesco [1 ]
机构：
[1] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland
[2] Ist Sci San Raffaele, Unit Lymphoid Malignancies, Milan, Italy
[3] Oncol Therapeut Dev, Clichy, France
[4] IOSI Oncol Inst Southern Switzerland, Bellinzona, Switzerland
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 37 条
  • [1] Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
    Gaudio, Eugenio
    Tarantelli, Chiara
    Ponzoni, Maurilio
    Odore, Elodie
    Rezai, Keyvan
    Bernasconi, Elena
    Cascione, Luciano
    Rinaldi, Andrea
    Stathis, Anastasios
    Riveiro, Eugenia
    Cvitkovic, Esteban
    Zucca, Emanuele
    Bertoni, Francesco
    [J]. ONCOTARGET, 2016, 7 (36) : 58142 - 58147
  • [2] OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models
    Berenguer-Daize, Caroline
    Astorgues-Xerri, Lucile
    Odore, Elodie
    Cayol, Mylene
    Cvitkovic, Esteban
    Noel, Kay
    Bekradda, Mohamed
    MacKenzie, Sarah
    Rezai, Keyvan
    Lokiec, Francois
    Riveiro, Maria E.
    Ouafik, L'Houcine
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (09) : 2047 - 2055
  • [3] Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts
    Vazquez, Ramiro
    Licandro, Simonetta Andrea
    Astorgues-Xerri, Lucile
    Lettera, Emanuele
    Panini, Nicolo
    Romano, Michela
    Erba, Eugenio
    Ubezio, Paolo
    Bello, Ezia
    Libener, Roberta
    Orecchia, Sara
    Grosso, Federica
    Riveiro, Maria Eugenia
    Cvitkovic, Esteban
    Bekradda, Mohamed
    D'Incalci, Maurizio
    Frapolli, Roberta
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 197 - 207
  • [4] The BRD-inhibitor OTX015 Shows Pre-clinical Activity in Diffuse Large B-cell Lymphoma (DLBCL)
    Bonetti, P.
    Ponzoni, M.
    Tibiletti, M. G.
    Stathis, A.
    Heirat, P.
    Zucca, E.
    Bertoni, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : 163 - 163
  • [5] Activity of OTX015 (MK-8628), a BET-Bromodomain Inhibitor, in Acute Myeloid Leukemia (AML) Progenitor Cells
    Roulin, Louise
    Ali, Ashfaq
    Masse, Aline
    Coude, Marie-Magdelaine
    Bluteau, Dominique
    Braun, Thorsten
    Berrou, Jeanning
    Bluteau, Olivier
    Delord, Marc
    Riveiro, Maria Eugenia
    Herait, Patrice Edouard
    Soulier, Jean
    Baruchel, Andre
    Gardin, Claude
    Dombret, Herve
    Itzykson, Raphael
    [J]. BLOOD, 2015, 126 (23)
  • [6] Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models
    Astorgues-Xerri, Lucile
    Vazquez, Ramiro
    Odore, Elodie
    Rezai, Keyvan
    Kahatt, Carmen
    Mackenzie, Sarah
    Bekradda, Mohamed
    Coude, Marie-Magdelaine
    Dombret, Herve
    Gardin, Claude
    Lokiec, Francois
    Raymond, Eric
    Noel, Kay
    Cvitkovic, Esteban
    Herait, Patrice
    Bertoni, Francesco
    Riveiro, Maria E.
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 3067 - 3070
  • [7] BET Bromodomain Inhibitor OTX015 Affects the Expression of Micrornas Involved in the Pathogenesis of Diffuse Large B-Cell Lymphoma
    Cascione, Luciano
    Gaudio, Eugenio
    Bernasconi, Elena
    Tarantelli, Chiara
    Rinaldi, Andrea
    Testoni, Monica
    Bomben, Riccardo
    Gattei, Valter
    Kwee, Ivo
    Stathis, Anastasios
    Riveiro, Maria Eugenia
    Zucca, Emanuele
    Bertoni, Francesco
    [J]. BLOOD, 2014, 124 (21)
  • [8] OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations
    Riveiro, Maria E.
    Astorgues-Xerri, Lucile
    Vazquez, Ramiro
    Frapolli, Roberta
    Kwee, Ivo
    Rinaldi, Andrea
    Odore, Elodie
    Rezai, Keyvan
    Bekradda, Mohamed
    Inghirami, Giorgio
    D'Incalci, Maurizio
    Noel, Kay
    Cvitkovic, Esteban
    Raymond, Eric
    Bertoni, Francesco
    [J]. ONCOTARGET, 2016, 7 (51) : 84675 - 84687
  • [9] Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes
    Boi, Michela
    Todaro, Maria
    Vurchio, Valentina
    Yang, Shao Ning
    Moon, John
    Kwee, Ivo
    Rinaldi, Andrea
    Pan, Heng
    Crescenzo, Ramona
    Cheng, Mangeng
    Cerchietti, Leandro
    Elemento, Olivier
    Riveiro, Maria E.
    Cvitkovic, Esteban
    Bertoni, Francesco
    Inghirami, Giorgio
    [J]. ONCOTARGET, 2016, 7 (48) : 79623 - 79639
  • [10] The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models
    Servidei, Tiziana
    Meco, Daniela
    Martini, Maurizio
    Battaglia, Alessandra
    Granitto, Alessia
    Buzzonetti, Alexia
    Babini, Gabriele
    Massimi, Luca
    Tamburrini, Gianpiero
    Scambia, Giovanni
    Ruggiero, Antonio
    Riccardi, Riccardo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 19
1234